Fresenius Medical Care AG (FMS)

NYQ – Real Time Price. Currency in USD

23.62

-0.25 (-1.05%)

Market open: Aug 12, 2026, 12:17 PM EDT

24.01

+0.14 (0.59%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Stock details

Previous close: 23.87$
Day's range: 23.85 - 24.54$
52-week range: 20.02 - 27.64$
Volume: 889 229
Average volume: 982 567
Beta: 0.3
EPS (TTM): 1.94
PE ratio (TTM): 12.32
Forward P/E: 10.17
Market cap: 12 974 608 122
Shares outstanding: 543 552 917
Dividend yield: $2.49 (2.49%)
Next earnings date: 2026-11-03
Sector: Healthcare
Industry: Medical Care Facilities

About the company

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the sup... read more

CEO: Helen Giza
Country: Germany
IPO Date: 1996-09-19
Employees: 109698
Fiscal Year End: January - December
Website: https://www.freseniusmedica...

Revenue Breakdown

Care Delivery / 67.45%

Care Enablement / 21.10%

Value-based Care / 11.45%

News

No Data

There are no news for this stock.

Chart: FMS

Loading Chart...

Overall Score

5.7 / 1057%

Octagon View

Strength & Weakness

Total debt $12.5B significantly exceeds cash reserves ($1.2B), raising financial stability concerns

Total current assets $8.8B exceed Total current liabilities $8.2B, highlighting excellent liquidity

Debt-to-equity ratio (0.8) is near the industry average, reflecting balanced leverage

Interest coverage ratio (6x) indicates the company easily manages its debt payments

The company generates positive free cash flow $724.8M, supporting its financial health

Financial Strength

NAME	RATIO	INDUSTRY	SCORE
Current ratio	1.07	1.59	7.0
Quick ratio	0.75	1.27	4.0
Debt to Equity	0.87	0.27	6.0
Debt to Assets	0.35	0.72	6.0
Interest coverage	5.54	25.51	10
Weighted average score			6.6

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)

Values in USD (B=Billions, M=Millions, K=Thousands)

METRIC	2022	2023	2024	2025	TTM
Total Revenue	20.38B	21.03B	20.92B	22.16B	22.66B
Gross Profit	5.58B	5.33B	5.15B	5.69B	5.97B
Operating Income	1.84B	1.72B	1.78B	2.13B	2.47B
Net Income	708M	539M	582M	1.10B	1.09B
EBITDA	3.65B	3.46B	3.44B	3.78B	4.15B

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAME	RATIO	INDUSTRY	SCORE
Gross margin %	26.95	13.98	5.0
Operating margin %	11.12	-0.07	6.0
Net margin %	4.49	-19.91	4.0
EBITDA margin %	18.46	93.67	6.0
Cash flow margin %	17.80	42.43	8.0
Weighted average score			5.8

Net Margin

Effectiveness

NAME	RATIO	INDUSTRY	SCORE
ROA	2.86	-4.62	4.0
ROE	6.75	15.99	5.0
ROIC	4.02	1.38	5.0
ROCE	2.15	10.56	5.0
Weighted average score			4.8

Estimated EPS vs Actual EPS

Forecast

NAME	REVENUE GROWTH	EPS GROWTH	SCORE
Current quarter	1.46	-1.74	2.0
Next quarter	-2.65	-20.26	1.0
Current year	-3.07	-6.95	1.0
Next year	3.22	3.9	4.0
Weighted average score			2.0

Analyst Rating

Growth

NAME	REVENUE	NET INCOME	EPS	FCF	SCORE
Q/Q	4.74	84.66	21.46	1582.54	8.5
Y/Y	4.06	-0.55	22.92	9.08	5.3
3y average	2.86	24.62	18.67	11.53	7.5
5y average	1.75	4.39	2.1	-6.71	2.8
Weighted average score					6.0

Revenue Growth Rate vs. Industry

Valuation

NAME	RATIO	INDUSTRY	SCORE
P/E	12.69	4.71	4.6
PEG (5yr expected)	0.86	0.04	8.0
P/S	0.61	3.18	8.8
P/B	0.89	-0.78	8.0
Weighted average score			7.4

DCF Model

DCF Model Period5 years

Discount rate8%

Perpetual growth rate3%

Revenue 5 year CAGR2.51%

FCF 5 year CAGR4

Fair value76.23$

Stock price23.87$

Dividend

NAME	CURRENT	INDUSTRY	SCORE
Dividend yield	3.33	3.33	8.0
Payout ratio	32.32	32.32	5.0
5-year dividend growth rate	2.60	2.60	4.0
Years of dividend increase	2.00	2.00	3.0
Weighted average score			5.0

Fair Value

$76.23

UndervaluedStock priceOvervalued

$23.87

Economic Moat

NAME	SCALE	SCORE
Market share	Wide	9.0
Intangible assets	Wide	8.0
Switching costs	Wide	9.0
Network effect	Narrow	4.0
Economies of scale	Wide	9.0
Weighted average score		7.8

About the company

CEO

Helen Giza

Country

Germany

IPO Date

1996-09-19

Employees

109698

Fiscal Year End

January - December

Website

https://www.freseniusmedica...

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Current ratio

1.07

1.59

7.0

Quick ratio

0.75

1.27

4.0

Debt to Equity

0.87

0.27

6.0

Debt to Assets

0.35

0.72

6.0

Interest coverage

5.54

25.51

Weighted average score

6.6

METRIC

2022

2023

2024

2025

TTM

Total Revenue

20.38B

21.03B

20.92B

22.16B

22.66B

Gross Profit

5.58B

5.33B

5.15B

5.69B

5.97B

Operating Income

1.84B

1.72B

1.78B

2.13B

2.47B

Net Income

708M

539M

582M

1.10B

1.09B

EBITDA

3.65B

3.46B

3.44B

3.78B

4.15B

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Gross margin %

26.95

13.98

5.0

Operating margin %

11.12

-0.07

6.0

Net margin %

4.49

-19.91

4.0

EBITDA margin %

18.46

93.67

6.0

Cash flow margin %

17.80

42.43

8.0

Weighted average score

5.8

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

ROA

2.86

-4.62

4.0

ROE

6.75

15.99

5.0

ROIC

4.02

1.38

5.0

ROCE

2.15

10.56

5.0

Weighted average score

4.8

NAME

REVENUE GROWTH

EPS GROWTH

SCORE

Current quarter

1.46

-1.74

2.0

Next quarter

-2.65

-20.26

1.0

Current year

-3.07

-6.95

1.0

Next year

3.22

3.9

4.0

Weighted average score

2.0

NAME

REVENUE

NET INCOME

EPS

FCF

SCORE

Q/Q

4.74

84.66

21.46

1582.54

8.5

Y/Y

4.06

-0.55

22.92

9.08

5.3

3y average

2.86

24.62

18.67

11.53

7.5

5y average

1.75

4.39

2.1

-6.71

2.8

Weighted average score

6.0

NAME

RATIO

INDUSTRY

5Q TREND

SCORE

P/E

12.69

4.71

4.6

PEG (5yr expected)

0.86

0.04

8.0

P/S

0.61

3.18

8.8

P/B

0.89

-0.78

8.0

Weighted average score

7.4

NAME

CURRENT

INDUSTRY

SCORE

Dividend yield

3.33

8.0

Payout ratio

32.32

5.0

5-year dividend growth rate

2.60

4.0

Years of dividend increase

2.00

3.0

Weighted average score

5.0

NAME

SCALE

SCORE

Market share

Wide

9.0

Intangible assets

Wide

8.0

Switching costs

Wide

9.0

Network effect

Narrow

4.0

Economies of scale

Wide

9.0

Weighted average score

7.8

Search stocks

Fresenius Medical Care AG (FMS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Fresenius Medical Care AG (FMS)

Stock details

About the company

Revenue Breakdown

News

Chart: FMS

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$76.23

$23.87

Economic Moat

Stock details

About the company

Revenue Breakdown

News

Chart: FMS

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$76.23

$23.87

Economic Moat